H.R. 10086: Diabetes Prevention Program Reauthorization Act of 2026
This bill would continue federal funding for the National Diabetes Prevention Program by updating the law’s authorization levels for future years.
What the bill does
Under current law, the program’s funding language is outdated. This bill replaces that language with specific authorized amounts for fiscal years 2027 through 2031. The amounts are:
- $39.3 million for fiscal year 2027
- $44.3 million for fiscal year 2028
- $49.3 million for fiscal year 2029
- $54.3 million for fiscal year 2030
- $59.3 million for fiscal year 2031
What the program is
The National Diabetes Prevention Program is a federal public health initiative aimed at helping people reduce their risk of developing type 2 diabetes. It typically supports prevention efforts such as lifestyle coaching, education, and related health services.
Practical effect
If enacted, the bill would not create a new program or change the basic structure of the existing one. Instead, it would extend and specify funding authorization so the program can continue operating in future years with set spending levels.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Aug. 13, 2026 | Introduced in House |
| Aug. 13, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.